🇺🇸 Lupron Depot in United States

FDA authorised Lupron Depot on 26 January 1989

Marketing authorisations

FDA — authorised 26 January 1989

  • Application: NDA019732
  • Marketing authorisation holder: ABBVIE ENDOCRINE INC
  • Status: supplemented

FDA — authorised 22 October 1990

  • Application: NDA020011
  • Marketing authorisation holder: ABBVIE ENDOCRINE INC
  • Status: supplemented

FDA — authorised 16 April 1993

  • Application: NDA020263
  • Marketing authorisation holder: ABBVIE ENDOCRINE INC
  • Status: supplemented

FDA — authorised 22 December 1995

  • Application: NDA020517
  • Marketing authorisation holder: ABBVIE ENDOCRINE INC
  • Status: supplemented

FDA — authorised 7 March 1997

  • Application: NDA020708
  • Marketing authorisation holder: ABBVIE ENDOCRINE INC
  • Status: supplemented

Other Oncology approved in United States

Frequently asked questions

Is Lupron Depot approved in United States?

Yes. FDA authorised it on 26 January 1989; FDA authorised it on 22 October 1990; FDA authorised it on 16 April 1993.

Who is the marketing authorisation holder for Lupron Depot in United States?

ABBVIE ENDOCRINE INC holds the US marketing authorisation.